LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article ; Online: Comparison of DNA quantification methodology used in the DNA extraction protocol for the UK Biobank cohort.

    Welsh, Samantha / Peakman, Tim / Sheard, Simon / Almond, Rachael

    BMC genomics

    2017  Volume 18, Issue 1, Page(s) 26

    Abstract: Background: UK Biobank is a large prospective cohort study in the UK established by the Medical Research Council (MRC) and the Wellcome Trust to enable approved researchers to investigate the role of genetic factors, environmental exposures and ... ...

    Abstract Background: UK Biobank is a large prospective cohort study in the UK established by the Medical Research Council (MRC) and the Wellcome Trust to enable approved researchers to investigate the role of genetic factors, environmental exposures and lifestyle in the causes of major diseases of late and middle age. A wide range of phenotypic data has been collected at recruitment and has recently been enhanced by the UK Biobank Genotyping Project. All UK Biobank participants (500,000) have been genotyped on either the UK Biobank Axiom® Array or the Affymetrix UK BiLEVE Axiom® Array and the workflow for preparing samples for genotyping is described. The genetic data is hoped to provide further insight into the genetics of disease. All data, including the genetic data, is available for access to approved researchers. Data for two methods of DNA quantification (ultraviolet-visible spectroscopy [UV/Vis]) measured on the Trinean DropSense™ 96 and PicoGreen®) were compared by two laboratories (UK Biobank and Affymetrix).
    Results: The sample processing workflow established at UK Biobank, for genotyping on the custom Affymetrix Axiom® array, resulted in high quality DNA (average DNA concentration 38.13 ng/μL, average 260/280 absorbance 1.91). The DNA generated high quality genotype data (average call rate 99.48% and pass rate 99.45%). The DNA concentration measured on the Trinean DropSense™ 96 at UK Biobank correlated well with DNA concentration measured by PicoGreen® at Affymetrix (r = 0.85).
    Conclusions: The UK Biobank Genotyping Project demonstrated that the high throughput DNA extraction protocol described generates high quality DNA suitable for genotyping on the Affymetrix Axiom array. The correlation between DNA concentration derived from UV/Vis and PicoGreen® quantification methods suggests, in large-scale genetic studies involving two laboratories, it may be possible to remove the DNA quantification step in one laboratory without affecting downstream analyses. This would result in reductions in cost and time to complete the project, allowing generation of genetic data faster and cheaper.
    MeSH term(s) Algorithms ; Biological Specimen Banks ; DNA/isolation & purification ; Genotyping Techniques/methods ; Genotyping Techniques/standards ; Humans ; Specimen Handling ; United Kingdom
    Chemical Substances DNA (9007-49-2)
    Language English
    Publishing date 2017-01-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041499-7
    ISSN 1471-2164 ; 1471-2164
    ISSN (online) 1471-2164
    ISSN 1471-2164
    DOI 10.1186/s12864-016-3391-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Organizing the organization.

    Peakman, Tim

    Drug discovery today

    2003  Volume 8, Issue 15, Page(s) 673

    MeSH term(s) Biotechnology/organization & administration ; Technology, Pharmaceutical/organization & administration
    Language English
    Publishing date 2003-08-08
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 1324988-5
    ISSN 1878-5832 ; 1359-6446
    ISSN (online) 1878-5832
    ISSN 1359-6446
    DOI 10.1016/s1359-6446(03)02757-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Current standards for the storage of human samples in biobanks.

    Peakman, Tim / Elliott, Paul

    Genome medicine

    2010  Volume 2, Issue 10, Page(s) 72

    Abstract: Biobanks are diverse in their design and purpose; the idea of fully harmonizing historical and future biobanks is unaffordable and unfeasible. Biobanks should focus their efforts instead on developing and maintaining high-quality collections of samples ... ...

    Abstract Biobanks are diverse in their design and purpose; the idea of fully harmonizing historical and future biobanks is unaffordable and unfeasible. Biobanks should focus their efforts instead on developing and maintaining high-quality collections of samples capable of providing a wide range of biological information using processes that minimize introduced variability. A full data audit trail on sample processing, archiving, and quality control procedures should also be provided. This should enable the data derived from biobanks to contribute as part of wider collaborative efforts with other similar resources.
    Language English
    Publishing date 2010-10-05
    Publishing country England
    Document type Editorial
    ZDB-ID 2484394-5
    ISSN 1756-994X ; 1756-994X
    ISSN (online) 1756-994X
    ISSN 1756-994X
    DOI 10.1186/gm193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?

    Hull, Caroline M / Peakman, Mark / Tree, Timothy I M

    Diabetologia

    2017  Volume 60, Issue 10, Page(s) 1839–1850

    Abstract: Type 1 diabetes is an autoimmune disease characterised by the destruction of insulin producing beta cells in the pancreas. Whilst it remains unclear what the original triggering factors for this destruction are, observations from the natural history of ... ...

    Abstract Type 1 diabetes is an autoimmune disease characterised by the destruction of insulin producing beta cells in the pancreas. Whilst it remains unclear what the original triggering factors for this destruction are, observations from the natural history of human type 1 diabetes, including incidence rates in twins, suggest that the disease results from a combination of genetic and environmental factors. Whilst many different immune cells have been implicated, including members of the innate and adaptive immune systems, a view has emerged over the past 10 years that beta cell damage is mediated by the combined actions of CD4
    MeSH term(s) Animals ; Diabetes Mellitus, Type 1/immunology ; Humans ; Immune Tolerance ; T-Lymphocytes, Regulatory/immunology
    Language English
    Publishing date 2017-08-02
    Publishing country Germany
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-017-4377-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: UK biobank data: come and get it.

    Allen, Naomi E / Sudlow, Cathie / Peakman, Tim / Collins, Rory

    Science translational medicine

    2014  Volume 6, Issue 224, Page(s) 224ed4

    MeSH term(s) Absorptiometry, Photon ; Adult ; Aged ; Biological Specimen Banks ; Female ; Humans ; Life Style ; Male ; Middle Aged ; United Kingdom
    Language English
    Publishing date 2014-02-20
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.3008601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Tracking immunodynamics by identification of S-G

    Muñoz-Ruiz, Miguel / Pujol-Autonell, Irma / Rhys, Hefin / Long, Heather M / Greco, Maria / Peakman, Mark / Tree, Tim / Hayday, Adrian C / Di Rosa, Francesca

    Journal of autoimmunity

    2020  Volume 112, Page(s) 102466

    Abstract: The ready availability of human blood makes it the first choice for immuno-monitoring. However, this has been largely confined to static metrics, particularly resting T cell phenotypes. Conversely, dynamic assessments have mostly relied on cell ... ...

    Abstract The ready availability of human blood makes it the first choice for immuno-monitoring. However, this has been largely confined to static metrics, particularly resting T cell phenotypes. Conversely, dynamic assessments have mostly relied on cell stimulation in vitro which is subject to multiple variables. Here, immunodynamic insights from the peripheral blood are shown to be obtainable by applying a revised approach to cell-cycle analysis. Specifically, refined flow cytometric protocols were employed, assuring the reliable quantification of T cells in the S-G
    MeSH term(s) Animals ; Cell Cycle Checkpoints/immunology ; Flow Cytometry/methods ; Humans ; Mice ; Mice, Transgenic ; Monitoring, Immunologic/methods ; T-Lymphocytes/immunology
    Language English
    Publishing date 2020-05-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639452-8
    ISSN 1095-9157 ; 0896-8411
    ISSN (online) 1095-9157
    ISSN 0896-8411
    DOI 10.1016/j.jaut.2020.102466
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Design and implementation of a high-throughput biological sample processing facility using modern manufacturing principles.

    Downey, Paul / Peakman, Tim C

    International journal of epidemiology

    2008  Volume 37 Suppl 1, Page(s) i46–50

    Abstract: Background: UK Biobank is a prospective study that is collecting biological samples and health and lifestyle data from 500 000 volunteer participants over a 4-year period. These data will be used to facilitate biological and medical research.: Methods! ...

    Abstract Background: UK Biobank is a prospective study that is collecting biological samples and health and lifestyle data from 500 000 volunteer participants over a 4-year period. These data will be used to facilitate biological and medical research.
    Methods: Modern manufacturing principles were used to direct the development of the sample processing facility and automated systems.
    Results: A fit for purpose facility comprising technology, systems, dedicated process, infrastructure and an appropriate staff structure has been implemented that will deliver and maintain a resource that will support the long-term goals of the UK Biobank study.
    Conclusions: Modern manufacturing principles are appropriate for use in the development of a high throughput biological sample processing facility.
    MeSH term(s) Autoanalysis ; Biological Specimen Banks/organization & administration ; Biological Specimen Banks/standards ; Biomedical Engineering ; Biomedical Technology ; Facility Design and Construction/standards ; Humans ; Practice Guidelines as Topic ; Quality Control ; Specimen Handling/methods ; United Kingdom
    Language English
    Publishing date 2008-04
    Publishing country England
    Document type Journal Article ; Validation Studies
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dyn031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Understanding the impact of pre-analytic variation in haematological and clinical chemistry analytes on the power of association studies.

    Gaye, Amadou / Peakman, Tim / Tobin, Martin D / Burton, Paul R

    International journal of epidemiology

    2014  Volume 43, Issue 5, Page(s) 1633–1644

    Abstract: Background: Errors, introduced through poor assessment of physical measurement or because of inconsistent or inappropriate standard operating procedures for collecting, processing, storing or analysing haematological and biochemistry analytes, have a ... ...

    Abstract Background: Errors, introduced through poor assessment of physical measurement or because of inconsistent or inappropriate standard operating procedures for collecting, processing, storing or analysing haematological and biochemistry analytes, have a negative impact on the power of association studies using the collected data. A dataset from UK Biobank was used to evaluate the impact of pre-analytical variability on the power of association studies.
    Methods: First, we estimated the proportion of the variance in analyte concentration that may be attributed to delay in processing using variance component analysis. Then, we captured the proportion of heterogeneity between subjects that is due to variability in the rate of degradation of analytes, by fitting a mixed model. Finally, we evaluated the impact of delay in processing on the power of a nested case-control study using a power calculator that we developed and which takes into account uncertainty in outcome and explanatory variables measurements.
    Results: The results showed that (i) the majority of the analytes investigated in our analysis, were stable over a period of 36 h and (ii) some analytes were unstable and the resulting pre-analytical variation substantially decreased the power of the study, under the settings we investigated.
    Conclusions: It is important to specify a limited delay in processing for analytes that are very sensitive to delayed assay. If the rate of degradation of an analyte varies between individuals, any delay introduces a bias which increases with increasing delay. If pre-analytical variation occurring due to delays in sample processing is ignored, it affects adversely the power of the studies that use the data.
    MeSH term(s) Analysis of Variance ; Biological Specimen Banks ; Biomedical Research ; Blood Chemical Analysis/methods ; Blood Chemical Analysis/standards ; Case-Control Studies ; Chemistry, Clinical ; Hematologic Tests/methods ; Humans ; Models, Theoretical ; Serum/chemistry ; Specimen Handling ; Uncertainty
    Language English
    Publishing date 2014-08-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dyu127
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The UK Biobank sample handling and storage validation studies.

    Peakman, Tim C / Elliott, Paul

    International journal of epidemiology

    2008  Volume 37 Suppl 1, Page(s) i2–6

    Abstract: Background: and aims UK Biobank is a large prospective study in the United Kingdom to investigate the role of genetic factors, environmental exposures and lifestyle in the causes of major diseases of late and middle age. It involves the collection of ... ...

    Abstract Background: and aims UK Biobank is a large prospective study in the United Kingdom to investigate the role of genetic factors, environmental exposures and lifestyle in the causes of major diseases of late and middle age. It involves the collection of blood and urine from 500 000 individuals aged between 40 and 69 years. How the samples are collected, processed and stored will have a major impact on the future scientific usefulness of the UK Biobank resource. A series of validation studies was recommended to test the robustness of the draft sample handling and storage protocol.
    Methods: Samples of blood and urine were collected from 40 healthy volunteers and either processed immediately according to the protocol or maintained at specified temperatures (4 degrees C for all tubes with the exception of vacutainers containing acid citrate dextrose that were maintained at 18 degrees C) for 12, 24 or 36 h prior to processing. A further sample was maintained for 24 h at 4 degrees C, processed and the aliquots frozen at -80 degrees C for 20 days and then thawed under controlled conditions. The stability of the samples was compared for the different times in a wide variety of assays.
    Results: The samples maintained at 4 degrees C were stable for at least 24 h after collection for a wide range of assays. Small but significant changes were observed in metabonomic studies in samples maintained at 4 degrees C for 36 h. There was no degradation of the samples for a range of biochemical assays after short-term freezing and thawing under controlled conditions. Whole blood maintained at 18 degrees C for 24 h in vacutainers containing acid citrate dextrose is suitable for viral immortalization techniques.
    Conclusions: The validation studies reported in this supplement provide justification for the sample handling and storage procedures adopted in the UK Biobank project.
    MeSH term(s) Adult ; Aged ; Anticoagulants ; Biological Specimen Banks/standards ; Blood Chemical Analysis/standards ; Blood Preservation/methods ; Blood Specimen Collection/methods ; Blood Specimen Collection/standards ; Citric Acid ; Cryopreservation ; Glucose/analogs & derivatives ; Humans ; Middle Aged ; Practice Guidelines as Topic ; Preservation, Biological/methods ; Preservation, Biological/standards ; Prospective Studies ; Specimen Handling/methods ; Specimen Handling/standards ; Temperature ; Time Factors ; United Kingdom ; Urinalysis/standards ; Urine
    Chemical Substances Anticoagulants ; acid citrate dextrose (13838-07-8) ; Citric Acid (2968PHW8QP) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2008-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Validation Studies
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dyn019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.

    Elliott, Paul / Peakman, Tim C

    International journal of epidemiology

    2008  Volume 37, Issue 2, Page(s) 234–244

    Abstract: Background: UK Biobank is a large prospective study in the UK to investigate the role of genetic factors, environmental exposures and lifestyle in the causes of major diseases of late and middle age. Extensive data and biological samples are being ... ...

    Abstract Background: UK Biobank is a large prospective study in the UK to investigate the role of genetic factors, environmental exposures and lifestyle in the causes of major diseases of late and middle age. Extensive data and biological samples are being collected from 500,000 participants aged between 40 and 69 years. The biological samples that are collected and how they are processed and stored will have a major impact on the future scientific usefulness of the UK Biobank resource.
    Aims: The aim of the UK Biobank sample handling and storage protocol is to specify methods for the collection and storage of participant samples that give maximum scientific return within the available budget. Processing or storage methods that, as far as can be predicted, will preclude current or future assays have been avoided.
    Methods: The protocol was developed through a review of the literature on sample handling and processing, wide consultation within the academic community and peer review. Protocol development addressed which samples should be collected, how and when they should be processed and how the processed samples should be stored to ensure their long-term integrity. The recommended protocol was extensively tested in a series of validation studies. UK Biobank collects about 45 ml blood and 9 ml of urine with minimal local processing from each participant using the vacutainer system. A variety of preservatives, anti-coagulants and clot accelerators is used appropriate to the expected end use of the samples. Collection of other material (hair, nails, saliva and faeces) was also considered but rejected for the full cohort. Blood and urine samples from participants are transported overnight by commercial courier to a central laboratory where they are processed and aliquots of urine, plasma, serum, white cells and red cells stored in ultra-low temperature archives. Aliquots of whole blood are also stored for potential future production of immortalized cell lines. A standard panel of haematology assays is completed on whole blood from all participants, since such assays need to be conducted on fresh samples (whereas other assays can be done on stored samples). By the end of the recruitment phase, 15 million sample aliquots will be stored in two geographically separate archives: 9.5 million in a -80 degrees C automated archive and 5.5 million in a manual liquid nitrogen archive at -180 degrees C. Because of the size of the study and the numbers of samples obtained from participants, the protocol stipulates a highly automated approach for the processing and storage of samples. Implementation of the processes, technology, systems and facilities has followed best practices used in manufacturing industry to reduce project risk and to build in quality and robustness. The data produced from sample collection, processing and storage are highly complex and are managed by a commercially available LIMS system fully integrated with the entire process.
    Conclusion: The sample handling and storage protocol adopted by UK Biobank provides quality assured and validated methods that are feasible within the available funding and reflect the size and aims of the project. Experience from recruiting and processing the first 40,000 participants to the study demonstrates that the adopted methods and technologies are fit-for-purpose and robust.
    MeSH term(s) Adult ; Aged ; Biological Specimen Banks/organization & administration ; Blood Banks ; Electronic Data Processing ; Humans ; Middle Aged ; Prospective Studies ; Quality Control ; Specimen Handling/methods ; Specimen Handling/standards ; Urinalysis
    Language English
    Publishing date 2008-04-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 187909-1
    ISSN 1464-3685 ; 0300-5771
    ISSN (online) 1464-3685
    ISSN 0300-5771
    DOI 10.1093/ije/dym276
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top